RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy

References

• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin 2008; 58:71 - 96; http://dx.doi.org/10.3322/CA.2007.0010; PMID: 18287387
   PubMed Web of Science ®Google Scholar
• Li D, Xie KP, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004; 363:1049 - 57; http://dx.doi.org/10.1016/S0140-6736(04)15841-8; PMID: 15051286
   PubMed Web of Science ®Google Scholar
• Linder S, Bostrom L, Nilsson B. Pancreatic cancer in Sweden 1980–2000: a population-based study of hospitalized patients concerning time trends in curative surgery and other interventional therapies. J Gastrointest Surg 2006; 10:672 - 8; http://dx.doi.org/10.1016/j.gassur.2005.10.005; PMID: 16713540
   PubMed Web of Science ®Google Scholar
• Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control 2006; 17:403 - 9; http://dx.doi.org/10.1007/s10552-005-0539-4; PMID: 16596292
   PubMed Web of Science ®Google Scholar
• Smeenk HG, Tran TC, Erdmann J, van Eijck CH, Jeekel J. Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?. Langenbecks Arch Surg 2005; 390:94 - 103; http://dx.doi.org/10.1007/s00423-004-0476-9; PMID: 15578211
   PubMed Web of Science ®Google Scholar
• Schäfer M, Mullhaupt B, Clavien PA. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 2002; 236:137 - 48; http://dx.doi.org/10.1097/00000658-200208000-00001; PMID: 12170018
   PubMed Web of Science ®Google Scholar
• Bergman AM, Pinedo HM, Peters GJ. Determinants of resistance to 2’,2’-difluorodeoxycytidine (gemcitabine). Drug Resist Updat 2002; 5:19 - 33; http://dx.doi.org/10.1016/S1368-7646(02)00002-X; PMID: 12127861
   PubMed Web of Science ®Google Scholar
• Heister E, Neves V, Tilmaciu C, Lipert K, Beltran VS, Coley HM, et al. Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy. Carbon 2009; 47:2152 - 60; http://dx.doi.org/10.1016/j.carbon.2009.03.057
   Web of Science ®Google Scholar
• Reddy LH, Couvreur P. Novel approaches to deliver gemcitabine to cancers. Curr Pharm Des 2008; 14:1124 - 37; http://dx.doi.org/10.2174/138161208784246216; PMID: 18473859
   PubMed Web of Science ®Google Scholar
• Yang J, Park SB, Yoon HG, Huh YM, Haam S. Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int J Pharm 2006; 324:185 - 90; http://dx.doi.org/10.1016/j.ijpharm.2006.06.029; PMID: 16872766
   PubMed Web of Science ®Google Scholar
• Celano M, Calvagno MG, Bulotta S, Paolino D, Arturi F, Rotiroti D, et al. Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells. BMC Cancer 2004; 4:63; http://dx.doi.org/10.1186/1471-2407-4-63; PMID: 15363094
   PubMed Web of Science ®Google Scholar
• Kurrat R, Prenosil JE, Ramsden JJ. Kinetics of human and bovine serum albumin adsorption at silica-titania surfaces. J Colloid Interface Sci 1997; 185:1 - 8; http://dx.doi.org/10.1006/jcis.1996.4528; PMID: 9056288
   PubMed Web of Science ®Google Scholar
• Gelamo EL, Tabak M. Spectroscopic studies on the interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants. Spectrochim Acta A Mol Biomol Spectrosc 2000; 56A:2255 - 71; http://dx.doi.org/10.1016/S1386-1425(00)00313-9; PMID: 11058071
   PubMed Web of Science ®Google Scholar
• Zhang L, Hou SX, Mao SJ, Wei DP, Song XJ, Lu Y. Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells. Int J Pharm 2004; 287:155 - 62; http://dx.doi.org/10.1016/j.ijpharm.2004.08.015; PMID: 15541922
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hekmataraa T, Herberta E, Kreuter J. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB). Eur J Pharm Biopharm 2009; 71:251 - 6; http://dx.doi.org/10.1016/j.ejpb.2008.08.021; PMID: 18805484
   PubMed Web of Science ®Google Scholar
• Buckley CD, Pilling D, Henriquez NV, Parsonage G, Threlfall K, Scheel-Toellner D, et al. RGD-peptides induce apoptosis by direct caspase-3 activation. Nature 1999; 397:534 - 9; http://dx.doi.org/10.1038/17409; PMID: 10028971
   PubMed Web of Science ®Google Scholar
• Anuradha CD, Kanno S, Hirano S. RGD peptide-induced apoptosis in human leukemia HL-60 cells requires caspase-3 activation. Cell Biol Toxicol 2000; 16:275 - 83; http://dx.doi.org/10.1023/A:1026758429238; PMID: 11201051
   PubMed Web of Science ®Google Scholar
• Madeja Z, Sroka J. Contact guidance of Walker carcinosarcoma cells by the underlying normal fibroblasts is inhibited by RGD-containing synthetic peptides. Folia Histochem Cytobiol 2002; 40:251 - 60; PMID: 12219835
   PubMed Web of Science ®Google Scholar
• Kang IC, Kim DS, Jang Y, Chung KH. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis. Biochem Biophys Res Commun 2000; 275:169 - 73; http://dx.doi.org/10.1006/bbrc.2000.3130; PMID: 10944460
   PubMed Web of Science ®Google Scholar
• Cui R, Takahashi F, Ohashi R, Gu T, Yoshioka M, Nishio K, et al. Abrogation of the interaction between osteopontin and αvβ3 integrin reduces tumor growth of human lung cancer cells in mice. Lung Cancer 2007; 57:302 - 10; http://dx.doi.org/10.1016/j.lungcan.2007.03.019; PMID: 17482311
   PubMed Web of Science ®Google Scholar
• Cannistra SA, Ottensmeier C, Niloff J, Orta B, DiCarlo J. Expression and Function of β1 and αvβ3 Integrins in Ovarian Cancer. Gynecol Oncol 1995; 58:216 - 25; http://dx.doi.org/10.1006/gyno.1995.1214; PMID: 7542622
   PubMed Web of Science ®Google Scholar
• Borrirukwanit K, Lafleur MA, Mercuri FA, Blick T, Price JT, Fridman R, et al. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by αVβ3 integrin in human breast cancer cells. Matrix Biol 2007; 26:291 - 305; http://dx.doi.org/10.1016/j.matbio.2006.10.014; PMID: 17175151
   PubMed Web of Science ®Google Scholar
• Tzukert K, Shimony N, Krasny L, Urieli-Shoval S, Gorodetsky R, Avrahami I, et al. Human melanoma cells expressing the αvβ3 integrin are partially protected from necrotic cell death induced by dynamic matrix detachment. Cancer Lett 2010; 290:174 - 81; http://dx.doi.org/10.1016/j.canlet.2009.09.007; PMID: 19804941
   PubMed Web of Science ®Google Scholar
• Holloway SE, Beck AW, Girard L, Jaber MR, Barnett CC Jr., Brekken RA, et al. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer. J Am Coll Surg 2005; 200:371 - 7; http://dx.doi.org/10.1016/j.jamcollsurg.2004.10.005; PMID: 15737847
   PubMed Web of Science ®Google Scholar
• Hosotani R, Kawaguchi M, Masui T, Koshiba T, Ida J, Fujimoto K, et al. Expression of integrin αvβ3 in pancreatic carcinoma: relation to mmp-2 activation and lymph node metastasis. Pancreas 2002; 25:30 - 5; http://dx.doi.org/10.1097/00006676-200208000-00021
   PubMedGoogle Scholar
• Li JM, Chen W, Wang H, Jin C, Yu XJ, Lu WY, et al. Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro. Acta Pharmacol Sin 2009; 30:1337 - 43; http://dx.doi.org/10.1038/aps.2009.125; PMID: 19730429
   PubMed Web of Science ®Google Scholar
• Tomita M, Sugi H, Ozawa K, Tsong TY, Yoshimura T. Targeting antigen-specific receptors on B lymphocytes to generate high yields of specific monoclonal antibodies directed against biologically active lower antigenic peptides within presenilin 1. J Immunol Methods 2001; 251:31 - 43; http://dx.doi.org/10.1016/S0022-1759(01)00299-X; PMID: 11292479
   PubMed Web of Science ®Google Scholar
• Du SL, Pan H, Lu WY, Wang J, Wu J, Wang JY. Cyclic RGD peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats. J Pharmacol Exp Ther 2007; 322:560 - 8; http://dx.doi.org/10.1124/jpet.107.122481; PMID: 17510318
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen XG, Peng WB, Liu CS. Uptake of oleoyl-chitosan nanoparticles by A549 cells. Nanomedicine 2008; 4:208 - 14; http://dx.doi.org/10.1016/j.nano.2008.03.006; PMID: 18508414
   PubMed Web of Science ®Google Scholar
• Merkel OM, Germershaus O, Wada CK, Tarcha PJ, Merdan T, Kissel T. Integrin αvβ3 targeted gene delivery using rgd peptidomimetic conjugates with copolymers of pegylated poly (ethylene imine). Bioconjug Chem 2009; 20:1270 - 80; http://dx.doi.org/10.1021/bc9001695; PMID: 19476331
   PubMed Web of Science ®Google Scholar
• Weber C, Coester C, Kreuter J, Langer K. Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm 2000; 194:91 - 102; http://dx.doi.org/10.1016/S0378-5173(99)00370-1; PMID: 10601688
   PubMed Web of Science ®Google Scholar
• Son SJ, Bai X, Lee SB. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications. Drug Discov Today 2007; 12:657 - 63; http://dx.doi.org/10.1016/j.drudis.2007.06.012; PMID: 17706548
   PubMed Web of Science ®Google Scholar
• Morgan MA, Meirovitz A, Davis MA, Kollar LE, Hassan MC, Lawrence TS. Radiotherapy combined with gemcitabine and oxaliplatinin pancreatic cancer cells. Transl Oncol 2008; 1:36 - 43; PMID: 18607506
   PubMed Web of Science ®Google Scholar